Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iCOMMIT for Smoking Cessation in Schizophrenia
NCT02420015Phase 4Completed
- Sponsor
- Duke University
- Start
- Mar 2017
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Duke University. Primary endpoint: Self-reported and Bio-verified Prolonged Smoking Abstinence at 6 months. Started Mar 2017; status: completed.
Beyond the preview
Go deeper on NCT02420015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02420015.